China Biologic’s $4.76 Billion Going-Private Transaction

Davis Polk and Harneys advised the special committee of the board of directors of China Biologic Products Holdings, Inc. in the transaction. Kirkland & Ellis and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here